In detail, CK1α silencing in MM cells reduced both β-catenin and RUNX2 expression in PCs, potentially counteracting the MSC osteogenic differentiation block induced by malignant PCs. The gene discussed is CSNK1A1; the disease is Miyoshi myopathy.